CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-08 | BIOGEN INC. 10% owner | Sale | −75,814 | $8.64 | $655K | 24,260,677 |
| 2021-12-07 | BIOGEN INC. 10% owner | Sale | −52,178 | $8.52 | $444K | 24,336,491 |
| 2021-12-02 | BIOGEN INC. 10% owner | Sale | −1,874 | $8.51 | $16K | 24,388,669 |
| 2021-12-01 | BIOGEN INC. 10% owner | Sale | −730 | $8.52 | $6K | 24,390,543 |
| 2021-11-26 | BIOGEN INC. 10% owner | Sale | −28,884 | $8.60 | $248K | 24,391,273 |
Page 9 of 9 · 165 trades